
In this study only 3 of the 296 patients undergoing corneal reshaping therapy had adverse events, but these events did not result in loss of BCVA. It concludes:
"Overnight Corneal Reshaping resulted in comparable safety and efficacy in temporarily reducing myopia for children younger than 12 years as it is for children older than 12 years and adults."
No comments:
Post a Comment
Leave a Comment or Question: